| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HCAT | Common Stock | Sale | -$166K | -2.95K | -2.16% | $56.40* | 134K | 15 Jun 2021 | Direct | F1, F2 |
| transaction | HCAT | Common Stock | Sale | -$27.4K | -480 | -0.36% | $57.09* | 133K | 15 Jun 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 10, 2021 in accordance with Rule 10b5-1. |
| F2 | Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.93 to $56.89, inclusive. |
| F3 | Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $56.96 to $57.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth Footnotes (2) and (3). |